Arzneimittelwerk Warngau develops and markets drug delivery systems.
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 4, 2018 | Series Unknown | €25M | 1 | European Investment Bank | — | Detail |
Jul 21, 2016 | Series C | €6M | 1 | Bayern Kapital | — | Detail |
Jun 3, 2015 | Series B | €7M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Investment Bank | Yes | Series Unknown |
Bayern Kapital | Yes | Series C |